Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Hemab Therapeutics Holdings, Inc. is a clinical-stage biotechnology company. The Company is developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience. It designs its assets to address critical gaps in the treatment of coagulation disorders. Its lead asset, sutacimig (HMB-001), is a bispecific antibody in Phase 1/2 clinical development for the prophylactic treatment of Glanzmann thrombasthenia and Phase 2 clinical development for the prophylactic treatment of Factor VII deficiency. Its second clinical-stage asset, HMB-002, is a monovalent antibody in Phase 1/2 clinical development for the subcutaneous prophylactic treatment of Von Willebrand Disease. HMB-002 is designed to address the underlying biological drivers of Von Willebrand Disease by increasing endogenous levels of von Willebrand factor (VWF), and Factor VIII, a blood coagulation protein. It is also advancing multiple preclinical and discovery-stage assets.
Find out what a historical investment in HEMAB THERAPEUTICS HOLDINGS would be worth today using our COAG stock calculator.
Buying COAG shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in HEMAB THERAPEUTICS HOLDINGS in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in COAG
What is the ticker symbol of HEMAB THERAPEUTICS HOLDINGS?
The ticker symbol for HEMAB THERAPEUTICS HOLDINGS is COAG.
How much is one share of COAG?
One share of COAG is valued at $39.86 as of 20 November 2026.
What is the market capitalisation of HEMAB THERAPEUTICS HOLDINGS COAG?
As of 20 November 2026 HEMAB THERAPEUTICS HOLDINGS has a market cap of $1.83B.
What is the 52-week high for HEMAB THERAPEUTICS HOLDINGS stock?
The HEMAB THERAPEUTICS HOLDINGS 52-week high stock price is $55.42.
What is the 52-week low for HEMAB THERAPEUTICS HOLDINGS stock?
The HEMAB THERAPEUTICS HOLDINGS 52-week low stock price is $23.00.
Can I buy COAG shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy COAG shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in COAG on Stake
Buy COAG from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of COAG from only US$10 with fractional shares